期刊文献+

全反式视黄酸调控乳腺癌细胞的增殖及机制研究 被引量:1

STUDY ON THE EFFECT ALL-TRANS RETINOIC ACID ON PROLIFERATION OF BREAST CANCER MDA-MB-231 CELLS AND UNDERLYING MECHANISM
原文传递
导出
摘要 目的研究全反式视黄酸(ATRA)对人乳腺癌MDA-MB-231细胞增殖及ATRA与X射线照射对视黄醇类X受体α(RXRα)表达水平的影响。方法 MTT法检测细胞增殖,Western blot检测RXRα表达水平。结果 ATRA浓度在100~1000 nmol/L,72 h可抑制细胞的增殖。观察不同时间100 nmol/L的ATRA作用,24 h内,促进MDA-MB-231细胞的增殖,而作用48 h后,可抑制细胞的增殖。ATRA在100~1000 nmol/L范围内可诱导RXRα的表达,且存在浓度依赖性。100 nmol/L的ATRA作用24 h即可诱导RXRα的表达,并且存在时间依赖性。X射线照射未能诱导RXRα的表达。结论 100~1000 nmol/L的ATRA作用48 h即可抑制MDA-MB-231细胞增殖,且其对MDA-MB-231细胞RXRα蛋白表达存在浓度和时间依赖性,为ATRA用于临床乳腺癌的治疗提供了理论基础,也提示RXRα可能是ATRA抑制乳腺癌细胞增殖的机制之一。 Objective To study the effect of all-trans retinoic acid(ATRA) on proliferation of breast cancer MDA-MB-231 cells,and its mechanism.Method Cell proliferation was evaluated by MTT assay,and protein expression of RXRα was determined by Western blot.Results ATRA 100-1000 nmol/L at 72 h inhibited the growth in dose dependent manner.After being treated with 100 nmol/L ATRA for less than 24h,obvious proliferation of MDA-MB-231 cells was observed,but showed inhibition when more than 48 h.Within 100-1000 nmol/L,ATRA could induce the expression of RXRα in concentration-dependent manner.After acting for 24 h,100 nmol/L ATRA could induce the expression of RXRα in time-dependent manner.X-ray irradiation at the rate of 0.5Gy/min could not induce the expression of RXRα.Conclusion ATRA 100-1000 nmol/L could inhibit proliferation of MDA-MB-231 cells after action for 48 h.The effect of ATRA on RXRα expression was concentration and time-dependent.RXRα might be the mechanism that ATRA regulated proliferation of MDA-MB-231 cells,and it provided the basis for ATRA to be used in clinic.
出处 《营养学报》 CAS CSCD 北大核心 2012年第5期432-435,共4页 Acta Nutrimenta Sinica
基金 国家自然科学基金(No.81001185)
关键词 ATRA 辐射 乳腺癌细胞 RXRα ATRA; radiation; breast cancer cell; RXRα
  • 相关文献

参考文献8

二级参考文献67

  • 1Michellys PY, Boehm MF, Chen JY, et al. Design and synthesis of novel RXR-selective modulators with improved pharmacological profile [ J ]. Bioorg Med Chem Lett, 2003,13 (22) :4071 - 4075.
  • 2Michellys PY, Ardecky RJ, Chen JH, et al. Design,synthesis, and structure-activity relationship studies of novel 6,7-locked-[ 7-( 2-alkoxy-3,5-dialkylbenzene ) -3-methylocta]-2,4,6-trienoic acids [ J ]. J Med Chem,2003,46 (19) :4087 - 4103.
  • 3Michellys PY, Arrigo JD, Grese TA, et al. Design,synthesis and structure-activity relationship of novel RXRselective modulators [ J ]. Bioorg Med Chem Lett, 2004,14:1593 - 1598.
  • 4Haffner CD, Lenhard JM, Miller AB, et al. Structurebased design of potent retinoid X receptor α agonists [J]. J Med Chem, 2004,47(8):2010 -2029.
  • 5Yen WC, Prudente RY, Lamph WW. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin ) and paclitaxel (Taxol) in mammary carcinoma [ J ]. Breast Cancer Res Treat,2004,88:141 - 148.
  • 6Yen WC, Manny R. Corpuz MR, et al. A selective retinoid X receptor agonist bexarotene (Targretin)prevents and overcomes acquired paclitaxel (Taxol)resistance in human non-small-cell Lung cancer (NSCLC) [J]. Clin Cancer Res, 2004,10:8656 - 8664.
  • 7Orfanos CE, Ehlert R, Gollnick H. The retinoids: a review of their clinical pharmacology and therapeutic use [J]. Drugs, 1987,34:459-503.
  • 8Hong WK, Sporn MB. Recent advances in chemoprevention of cancer [ J ]. Science, 1997, 278(5340) :1073 - 1077.
  • 9Orfanos CE, Zouboulis CC, Almond-Roesler, B, et al.Current use and future potential role of retinoids in dermatology [J]. Drugs, 1997,53:358 - 387.
  • 10Isserman I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [ J ]. Nature, 1990,347 (6294) :645 - 650.

共引文献15

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部